M. Hemels Et Al. , "Cost-effectiveness analysis of escitalopram in the treatment of major depressive disorder in Turkey," VALUE IN HEALTH , vol.8, no.3, pp.392, 2005
Hemels, M. Et Al. 2005. Cost-effectiveness analysis of escitalopram in the treatment of major depressive disorder in Turkey. VALUE IN HEALTH , vol.8, no.3 , 392.
Hemels, M., Karamustafyoglu, O., Ozmen, E., Dilsad, S., & Mene, S., (2005). Cost-effectiveness analysis of escitalopram in the treatment of major depressive disorder in Turkey. VALUE IN HEALTH , vol.8, no.3, 392.
Hemels, ME Et Al. "Cost-effectiveness analysis of escitalopram in the treatment of major depressive disorder in Turkey," VALUE IN HEALTH , vol.8, no.3, 392, 2005
Hemels, ME Et Al. "Cost-effectiveness analysis of escitalopram in the treatment of major depressive disorder in Turkey." VALUE IN HEALTH , vol.8, no.3, pp.392, 2005
Hemels, M. Et Al. (2005) . "Cost-effectiveness analysis of escitalopram in the treatment of major depressive disorder in Turkey." VALUE IN HEALTH , vol.8, no.3, p.392.
@article{article, author={ME Hemels Et Al. }, title={Cost-effectiveness analysis of escitalopram in the treatment of major depressive disorder in Turkey}, journal={VALUE IN HEALTH}, year=2005, pages={392} }